Topics

MODAG Company Profile

19:59 EDT 20th July 2019 | BioPortfolio

Multiple System Atrophy (MSA) is a currently non-curable neurological disorder characterized by neurodegeneration in several parts of the brain including the basal ganglia and the cerebellum. It is characterized by a build-up of pathologically aggregated alpha-synuclein proteins in neuronal and glial cells. Patients experience an array of symptoms, including movement, balance, and autonomic function disorders. Current drugs do not address the cause of the disease and are only capable of treating symptoms which progress alongside the disease. MSA is classified as a rare disease with an incident rate of approximately 0.6 cases per 100,000 people annually in the European Union. In Europe/US/JP, there are approximately 50,000 MSA patients. The mean age of onset of the disease is in the sixth decade of life. The mean survival period after the onset of the disease is 6-10 years.


News Articles [3 Associated News Articles listed on BioPortfolio]

MODAG raises €12M series A to test approach to neurodegeneration

German Biotech Will Target Parkinsonian Disorders with €12M Series A

Modag has developed a candidate drug targeting the neurodegenerative disease multiple system atrophy, which it plans to take to the clinic with €12M in Series A funds.  Multiple system atrophy is a...

MODAG Launches Out of Stealth Mode with Series A Financing of EUR 12 Million to Develop Treatments for Parkinsonian Disorders, Including Multiple System Atrophy

-- Dr. Torsten Matthias appointed CEO, scientific founder Prof. Dr. Armin Giese joins as CSO -- -- SERY technology in-licensed from Max-Planck Innovation GmbH to design next-generation candidate po...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

MODAG

Multiple System Atrophy (MSA) is a currently non-curable neurological disorder characterized by neurodegeneration in several parts of the brain including the basal ganglia and the cerebellum. It is c...

More Information about "MODAG" on BioPortfolio

We have published hundreds of MODAG news stories on BioPortfolio along with dozens of MODAG Clinical Trials and PubMed Articles about MODAG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MODAG Companies in our database. You can also find out about relevant MODAG Drugs and Medications on this site too.

Quick Search

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record